Envisioning the future of ophthalmology

About this session

Ophthalmology is entering a new era of innovation with emerging therapies, novel delivery systems, and technological advances transforming the prevention and treatment of vision-threatening conditions. This session explores what the latest data reveals about new approaches to retinal diseases, glaucoma, and other ophthalmic conditions, and examines the investment and partnership activity driving the field forward.

Speakers

• SR

  Suguna Rachakonda

  SVP, Strategy & BD · MICRO CRISPR

  Moderator

• PB

  Peter Benz

  Head of Strategic Partnering for Eye Health · Boehringer Ingelheim

  Panelist

• NM

  Natalia Misciatelli

  CEO · AAVantgarde

  Panelist

• SS

  Sara Secall

  General Partner · Inveready

  Panelist

• PV

  Prabhu Velusami

  Senior Director, Early Innovation Partnering (Retina & Data Sciences) · Johnson & Johnson Innovation

  Panelist